Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,500
- 试验地点
- 2
- 主要终点
- The environmental impact of redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
研究概览
简要总结
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs.
The main questions it aims to answer are:
- What are the cost-savings of redispensing unused oral anticancer drugs?
- What is the environmental impact of redispensing unused oral anticancer drugs?
Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal.
Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of all ages
- •A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).
排除标准
- •Patients that do not understand the Dutch or English language, in written or spoken.
- •Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package
结局指标
主要结局
The environmental impact of redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
时间窗: From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months
Environmental impact will be measured in CO2-eq
Cost-savings obtained by redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
时间窗: From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months.
Cost savings will be measured in euros
次要结局
- Patients' reasons for not wanting to participate in a redispensing program for oral anticancer drugs.(From date of first invitation to participate in the study until the end of the recruitment period, up to 8 months.)
- The proportion of usability of returned medication for redispensing and the reasons for quality disapproval.(From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months)
- The proportion of returned unused oral anticancer drugs and reasons thereof.(From date of first dispensing unit the date of last unused medication package returning to the pharmacy, assessed up to 16 months)